This report presents a strategic analysis of the UK Biomaterials in Healthcare Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the UK Biomaterials in Healthcare Market, offering unmatched value, accuracy and expert insights.
In 2020, total healthcare spending in the United Kingdom was £257.6 billion, or £3,840 per person. In nominal terms, healthcare spending increased by 15.7 percent in 2020, or 10.0 percent in real terms after inflation; this was the greatest growth rate since the series began in 1997.
In 2020, The total current healthcare expenditure in the United Kingdom was 12.0% of the GDP, up from 9.9% in 2019. Preventive care spending reached £15.7 billion in 2020, up 40.8 percent in real terms, owing partly to increased government spending during the coronavirus (COVID-19) pandemic. The market size, measured by revenue, of the Pharmaceutical Wholesaling industry, is £64.9bn in 2022.
To develop universal health care, deal with medical emergencies, and encourage healthier populations, access to high-quality, reasonably priced, and suitable health products is essential.
Without medical devices, it would be impossible to do regular medical procedures like bandaging a damaged ankle, diagnosing HIV/AIDS, implanting an artificial hip, or performing any type of surgery. Medical gadgets are utilized by laypeople at home, paramedical workers and clinicians at outlying clinics, optometrists, dentists, and healthcare professionals in cutting-edge medical facilities, for screening and prevention, as well as in palliative care. These medical technologies are employed in the diagnosis and treatment of acute and chronic illnesses, as well as in the support of persons with disabilities.
In today's healthcare, biomaterials are crucial. They are utilized in medical applications to improve, replace, or support damaged tissue or a biological function. They can be natural or synthetic. A biomaterial can be made from materials such as metals, ceramics, plastic, polymers, and even biological cells and tissues. They have a wide range of uses, including in drug delivery systems, medical implants (such as heart valves, stents, grafts, artificial joints, ligaments, and tendons), and ways to assist the healing of human tissues (such as sutures and clips). The prevalence of cardiovascular disorders is on the rise, implantable device demand is increasing, and governmental and non-governmental organizations are providing more funding for the development of innovative biomaterials, all of which are contributing factors to the market growth for these materials.
The Europe Biomaterials in Healthcare Market size is at around US $ 31.3 Bn in 2021 and is projected to reach US $ 61.57 Bn in 2030, exhibiting a CAGR of 14.3% during the forecast period.
Market Growth Drivers Analysis
Over the past few years, biomaterials have become more in demand and used in a variety of medical applications. The development of innovative biomaterials is being supported by investments, funding, and grants from a number of government agencies and academic institutions. For instance, Drexel University awarded the National Science Foundation $200,000 in March 2018 to support research on the impact of macrophage behaviour control by biomaterials on biomaterial vascularization. Such research and funding initiatives should encourage the creation of novel biomaterials, opening up a wide range of potential for the market's expansion.
Before any new biomaterials can be approved for marketing, it must be shown that it is both safe and effective. The FDA has established tight criteria and restrictions for the approval procedure in the US. Implantable pacemakers, stents, and heart valves are examples of biomaterial-based goods that are categorized by the FDA as Class III devices, which are those that carry the greatest risk of sickness or harm. As a result, the premarket approval application procedure is used for these products (the most stringent type of device marketing application).
Key players in the biomaterials market include BASF SE, Covestro AG, Celanese Corporation, Corbion, Royal DSM, Evonik Industries, Carpenter Technology Corporation, Berkeley Advanced Biomaterials, Cam Bioceramics B.V., CoorsTek Inc., CeramTec, and Gelita AG
1. Report Description of the UK Biomaterials in Healthcare Market
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. UK Biomaterials in Healthcare Market Executive Summary
2.1 UK Biomaterials in Healthcare Market – Industry Snapshot & key buying criteria, 2021-2030
2.2 Market Size, Growth Prospects, and Key findings
3. Market Dynamics of UK Biomaterials in Healthcare Market
3.1 Market Growth Drivers Analysis
3.2 Market Restrains Analysis
4. UK Biomaterials in Healthcare Market Segmentation
4.1 By Type
4.1.1 Metallic Biomaterials
22.214.171.124 Stainless Steel
126.96.36.199 Titanium & Titanium Alloys
188.8.131.52 Cobalt-Chrome Alloys
?4.1.2 Polymeric Biomaterials
184.108.40.206 Silicone Rubber
220.127.116.11 Other Polymeric Biomaterials
18.104.22.168 Calcium Phosphate
22.214.171.124 Aluminum Oxide
126.96.36.199 Calcium Sulfate
4.1.4 Natural Biomaterials
188.8.131.52 Hyaluronic Acid
4.2 By Application
184.108.40.206 Implantable Cardiac Defibrillators
220.127.116.11 Heart Valves
18.104.22.168 Vascular Grafts
22.214.171.124.1 Joint Replacement
126.96.36.199.2 Knee Replacement
188.8.131.52.3 Hip Replacement
184.108.40.206.4 Shoulder Replacement
220.127.116.11 Bioresorbable Tissue Fixation
18.104.22.168.1 Suture Anchors
22.214.171.124.2 Interference Screws
126.96.36.199.3 Meniscal Repair Tacks
188.8.131.52.1 Spinal Fusion Surgeries
184.108.40.206.2 Minimally Invasive Fusion Surgeries
220.127.116.11.3 Motion Preservation & Dynamic Stabilization Surgeries
18.104.22.168.3.1 Pedicle-Based Rod Systems
22.214.171.124.3.2 Interspinous Spacers
126.96.36.199.3.3 Artificial Discs
188.8.131.52.4 Fracture Fixation Devices
184.108.40.206.4.1 Bone Plates
220.127.116.11.5 Synthetics Bone Grafts
18.104.22.168 Contact Lenses
22.214.171.124 Intraocular Lenses
126.96.36.199 Functional Replacement of Ocular Tissues
188.8.131.52 Synthetic Corneas
184.108.40.206 Dental Implants
220.127.116.11 Dental Bone Grafts & Substitutes
18.104.22.168 Dental Membranes
22.214.171.124 Tissue Regeneration
4.2.5 Plastic Surgery
126.96.36.199 Soft-Tissue Fillers
188.8.131.52 Craniofacial Surgery
4.2.6 Wound Healing
184.108.40.206 Wound Closure Devices
220.127.116.11 Surgical Hemostats
18.104.22.168 Internal Tissue Sealants
22.214.171.124 Adhesion Barriers
126.96.36.199 Hernia Meshes
4.2.7 Tissue Engineering
188.8.131.52 Scaffolds for Regenerative Medicine
184.108.40.206 Nanomaterials for Biosensing
220.127.116.11 Tailoring of Inorganic Nanoparticles
4.2.8 Neurological/Central Nervous System Applications
18.104.22.168 Shunting Systems
22.214.171.124 Cortical Neural Prosthetics
126.96.36.199 Hydrogel Scaffolds for CNS Repair
188.8.131.52 Neural Stem Cell Encapsulation
4.2.9 Other Applications
184.108.40.206 Drug Delivery Systems
220.127.116.11 Gastrointestinal Applications
18.104.22.168 Bariatric Surgery
22.214.171.124 Urinary Applications
5. UK Biomaterials in Healthcare Market Share
5.1 Market Analysis, Insights, and Forecast – By Revenue
6. Competitive Landscape
6.1 Major Top Market Players
7. Key Company Profiles
7.1 Company 1
7.1.2 Financial Performance
7.1.3 Product & Services
7.1.4 Strategic initiatives
7.2 Company 2
7.2.2 Financial Performance
7.2.3 Product & Services
7.2.4 Strategic initiatives
7.3 Company 3
7.3.2 Financial Performance
7.3.3 Product & Services
7.3.4 Strategic initiatives
7.4 Company 4
7.4.2 Financial Performance
7.4.3 Product & Services
7.4.4 Strategic initiatives
7.5 Company 5
7.5.2 Financial Performance
7.5.3 Product & Services
7.5.4 Strategic initiatives
8. Healthcare Policies and Regulatory Landscape
8.1 Healthcare Policies in UK
8.2 Regulatory Framework in UK
8.3 Pricing & Reimbursement Scenario in UK Biomaterials in Healthcare Market
9. Factors Driving Future Growth
9.1 New Trends and Development UK Biomaterials in Healthcare Market
9.2 Future Opportunities
10. Strategic Recommendations
By Type (Revenue, USD Billion):
Based on type, the market is segmented into Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, and Natural Biomaterials. The Metallic Biomaterials segment accounted for the largest share of the UK market in 2019. The growing geriatric population UKly is expected to drive growth for this segment.
By Application (Revenue, USD Billion):
The cardiovascular, orthopaedic, dental, plastic surgery, wound healing, tissue engineering, ophthalmology, neurological/CNS, and other applications segments are made up of the biomaterials market. The market category for wound healing is anticipated to have the highest CAGR in 2019. The market will increase as a result of factors including expanding healthcare infrastructure, a large population pool, a rising diabetic population, and rising healthcare spending. Surgical Guides
Insights10 will provide you with the reports within 10 key parameters which are:
Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.
Stage I: Market Data Collection
Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.
Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.
Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:
Stage II: Market Data Analysis and Statistical Model
Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.
Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.
The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.
The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.
Data Triangulation & Validation:
Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.
We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.
Stage III: Interpretation and Presentation
Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)
Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to oﬀer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.
Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.
This report addresses